1. Home
  2. Analysis
  3. Hydrocortisone
  4. Humalog-kwikpen

Hydrocortisone and Humalog kwikpen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 7 people who take Hydrocortisone and Humalog kwikpen. Common interactions include acidosis among females, and urinary tract infection among males.

The phase IV clinical study analyzes what interactions people who take Hydrocortisone and Humalog kwikpen have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

On Sep, 25, 2023

7 people who take Hydrocortisone and Humalog kwikpen together, and have interactions are studied.

What is Hydrocortisone?

Hydrocortisone has active ingredients of hydrocortisone. It is used in addison's disease. Currently, eHealthMe is studying from 33,376 Hydrocortisone users.

What is Humalog kwikpen?

Humalog kwikpen has active ingredients of insulin lispro recombinant. It is used in diabetes. Currently, eHealthMe is studying from 3,275 Humalog kwikpen users.

Number of Hydrocortisone and Humalog kwikpen reports submitted per year:

Hydrocortisone and Humalog kwikpen drug interactions.

Common Hydrocortisone and Humalog Kwikpen drug interactions by gender *:

female:

  1. Acidosis
  2. Blood glucose decreased
  3. Blood glucose increased
  4. Drug ineffective
  5. Fluid retention
  6. Respiration

male:

  1. Urinary tract infection
  2. Diabetic ketoacidosis
  3. Vision blurred
  4. Sepsis
  5. Drug hypersensitivity
  6. Fatigue
  7. Rash
  8. Skin cancer
  9. Dysarthria
  10. Gait disturbance

Common Hydrocortisone and Humalog Kwikpen drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Gait disturbance
  2. Haemorrhage intracranial
  3. Vision blurred
  4. Diabetic ketoacidosis
  5. Sepsis
  6. Urinary tract infection
  7. Dysarthria

60+:

  1. Acidosis
  2. Blood glucose decreased
  3. Blood glucose increased
  4. Drug ineffective
  5. Fluid retention
  6. Respiration

* Approximation only. Some reports may have incomplete information.

Do you take Hydrocortisone and Humalog kwikpen?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Hydrocortisone side effects:

Browse all side effects of Hydrocortisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Humalog kwikpen side effects:

Browse all side effects of Humalog kwikpen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Hydrocortisone interactions:

Browse all interactions between Hydrocortisone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Humalog kwikpen interactions:

Browse all interactions between Humalog kwikpen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone and insulin lispro recombinant (the active ingredients of Hydrocortisone and Humalog kwikpen, respectively), and Hydrocortisone and Humalog kwikpen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Hydrocortisone and Humalog kwikpen.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.